We were excited to attend EUROTOX 2025 in Athens, Greece, from 14–17 September. This year’s theme, “Toxicology addresses society’s real-life risks for sustainable health and well-being,” highlighted the crucial role of science and technology in building a healthier, more sustainable future. In line with this theme, Lhasa actively contributed to the scientific programme with a […]
EUROTOX Congress 2025 Read More »
We held this practical, workshop-style webinar designed to help you confidently apply in silico tools for ICH M7 risk assessments. This session was ideal for professionals involved in the evaluation of potentially mutagenic impurities, whether you’re new to in silico methods or looking to deepen your expertise. We walked through real compound examples using Derek
Step-by-step ICH M7: Interactive case studies with Lhasa in silico tools Read More »
9 am (Mexico – CST), 10am (Colombia – COT), 12 pm (Argentina – ART) This Spanish-language webinar guided attendees through real-life case studies using the in silico tool Zeneth to solve stability problems at various stages of the drug development workflow. Case studies included: Nitrosamine risk assessment Identification of degradants Regulatory deficiency letter troubleshooting The webinar
Please note this webinar was hosted in Japanese. 15:30 (JST) In this webinar we explored the scientific and regulatory challenges of applying ICH M7 Control Options 3 and 4 to manage nitrosamine impurities in pharmaceuticals. Drawing on real-world case studies from the recently published journal article Industrial Case Studies Demonstrating Applicability of ICH M7 Control
Nitrosamine control: Real-world applications of ICH M7 Options 3 & 4 (Japanese) Read More »
Save the date for our symposia in Mexico, co-hosted by CTR Scientific! Our one-day event brought together experts from the pharmaceutical industry and regulatory bodies to support Mexico’s alignment with international best practices. This event took place in two locations: • 22th July 2025 – Ciudad de México (BelAir Unique a Wyndham Hotel)• 24th July
Guadalajara Symposium 2025: Shaping the Future of Pharma & Regulation Read More »
Save the date for our symposia in Mexico, co-hosted by CTR Scientific! Our one-day event brought together experts from the pharmaceutical industry and regulatory bodies to support Mexico’s alignment with international best practices. This event took place in two locations: • 22th July 2025 – Ciudad de México (BelAir Unique a Wyndham Hotel)• 24th
Mexico City Symposium 2025: Shaping the Future of Pharma & Regulation Read More »
니트로사민 관리 전략 – ICH M7 옵션 3 및 4의 실제 적용 Please note this webinar will be in Korean, or dubbed in Korean with Korean subtitles only. 15:30 (KST) In this webinar from Lhasa Limited and BITEK, we explore the scientific and regulatory challenges of applying ICH M7 Control Options 3 and 4 to
Nitrosamine control: Real-world applications of ICH M7 Options 3 & 4 (Korean) Read More »
We were delighted to host the Lhasa Brazil Symposium: Aligning Pharma & Regulatory Standards Globally, which took place in São Paulo, Brazil. The one-day event on Monday, 14th July, brought together key representatives from the pharmaceutical industry and regulatory bodies, encouraging collaboration and aligning Brazil with global best practices. Throughout the day, attendees gained
Lhasa Brazil Symposium 2025: Aligning Pharma & Regulatory Standards Globally Read More »
We were excited to attend the 65th Annual Meeting of the Society for Birth Defects Research and Prevention, which took place at the Hilton Denver City Centre in Denver, Colorado. The Society brings together experts from diverse scientific fields to better understand and protect against potential hazards to developing embryos, fetuses, children, and adults. The
65th Annual Meeting of the Society for Birth Defect Research and Prevention Read More »
Regulatory frameworks like ICH M7 have established in silico tools as a trusted method for evaluating the mutagenic potential of impurities, reducing reliance on animal testing and accelerating risk assessments. While these tools are widely accepted for mutagenicity, researchers and regulators are now looking at their potential for broader genotoxicity evaluations, including chromosome damage. As
The evolving role of in silico tools in genotoxicity assessments Read More »